Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 42, 2007, Pages 16702-16707

  Tsujikawa, Kazutake ^a   Yayama, Katsutoshi ^c   Hayashi, Tamon ^a   Matsushita, Hiroaki ^a   Yamaguchi, Taijiro ^a   Shigeno, Tomomi ^a   Ogitani, Yusuke ^a   Hirayama, Megumi ^a   Kato, Tetsuya ^a   Fukada, So Ichiro ^a   Takatori, Shingo ^d   Kawasaki, Hiromu ^d   Okamoto, Hiroshi ^c   Ikawa, Masahito ^b   Okabe, Masaru ^b   Yamamoto, Hiroshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

Adrenomedullin; Calcitonin gene related peptide; Dendritic cells; Gene disrupted mice; Neuropeptide

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN RECEPTOR LIKE RECEPTOR; CYTOKINE; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NEUROPEPTIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE TARGETING; HEART RATE; HYPERTENSION; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASODILATATION;

ANIMALS; AORTA; BONE MARROW; CALCITONIN GENE-RELATED PEPTIDE; CYTOKINES; DENDRITIC CELLS; HYPERTENSION; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; MICE, MUTANT STRAINS; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; VASODILATION;

MUS;

EID: 36749099014     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0705974104     Document Type: Article

References (33)

1. Wimalawansa SJ (1996) Endocr Rev 17:533-585.
2. Mulderry PK, Ghatei MA, Spokes RA, Jones PM, Pierson AM, Hamid QA, Kanse S, Amara SG, Burrin JM, Legon S, et al. (1988) Neuroscience 25:195-205.
3. Xing L, Guo J, Wang X (2000) J Immunol 165:4359-4366.
4. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I (1985) Nature 313:54-56.
5. Bell D, McDermott BJ (1996) Pharmacol Rev 48:253-288.
6. Salmon AM, Damaj MI, Marubio LM, Epping-Jordan MP, Merlo-Pich E, Changeux JP (2001) Nat Neurosci 4:357-358.
7. Ichinose M, Sawada M (1996) Peptides 17:1405-1414.
8. Hosoi J, Murphy GF, Egan CL, Lerner EA, Grabbe S, Asahina A, Granstein RD (1993) Nature 363:159-163.
9. Tokoyoda K, Tsujikawa K, Matsushita H, Ono Y, Hayashi T, Harada Y, Abe R, Kubo M, Yamamoto H (2004) Int Immunol 16:643-653.
10. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H (1998) Neuroimmunomodulation 5:9-15.
11. Dennis T, Fournier A, Cadieux A, Pomerleau F, Jolicoeur FB, St Pierre S, Quirion R (1990) J Pharmacol Exp Ther 254:123-128.
12. Dennis T, Fournier A, St Pierre S, Quirion R (1989) J Pharmacol Exp Ther 251:718-725.
13. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM (1998) Nature 393:333-339.
14. Miyauchi K, Tadotsu N, Hayashi T, Ono Y, Tokoyoda K, Tsujikawa K, Yamamoto H (2002) Neuropeptides 36:22-33.
15. Hinson JP, Kapas S, Smith DM (2000) Endocr Rev 21:138-167.
16. Steiner S, Muff R, Gujer R, Fischer JA, Born W (2002) Biochemistry 41:11398-11404.
17. Sexton PM, Albiston A, Morfis M, Tilakaratne N (2001) Cell Signal 13:73-83.
18. Aiyar N, Rand K, Elshourbagy NA, Zeng Z, Adamou JE, Bergsma DJ, Li Y (1996) J Biol Chem 271:11325-11329.
19. Tybulewicz VL, Crawford CE, Jackson PK, Bronson RT, Mulligan RC (1991) Cell 65:1153-1163.
20. Hay DL, Howitt SG, Conner AC, Schindler M, Smith DM, Poyner DR (2003) Br J Pharmacol 140:477-486.
21. Nagoshi Y, Kuwasako K, Ito K, Uemura T, Kato J, Kitamura K, Eto T (2002) Eur J Pharmacol 450:237-243.
22. Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, Niswender KD, Loewy AD, Magnuson MA, Sanes JR, et al. (1999) Mol Cell Neurosci 14:99-120.
23. Gangula PR, Zhao H, Supowit SC, Wimalawansa SJ, Dipette DJ, Westlund KN, Gagel RF, Yallampalli C (2000) Hypertension 35:470-475.
24. Oh-hashi Y, Shindo T, Kurihara Y, Imai T, Wang Y, Morita H, Imai Y, Kayaba Y, Nishimatsu H, Suematsu Y, et al. (2001) Circ Res 89:983-990.
25. Deng PY, Ye F, Zhu HQ, Cai WJ, Deng HW, Li YJ (2003) Regul Pept 114:175-182.
26. Beglinger C, Born W, Munch R, Kurtz A, Gutzwiller JP, Jager K, Fischer JA (1991) Peptides 12:1347-1351.
27. Arnalich F, Sanchez JF, Martinez M, Jimenez M, Lopez J, Vazquez JJ, Hernanz A (1995) Life Sci 56:75-81.
28. Dakhama A, Larsen GL, Gelfand EW (2004) Curr Opin Pharmacol 4:215-220.
29. Eysselein VE, Reinshagen M, Patel A, Davis W, Nast C, Sternini C (1992) Ann NY Acad Sci 657:319-327.
30. Asahina A, Moro O, Hosoi J, Lerner EA, Xu S, Takashima A, Granstein RD (1995) Proc Natl Acad Sci USA 92:8323-8327.
31. Monneret G, Pachot A, Laroche B, Picollet J, Bienvenu J (2000) Cytokine 12:762-764.
32. Sakai K, Miyazaki J (1997) Biochem Biophys Res Commun 237:318-324.
33. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G (1999) J Immunol Methods 223:77-92.